Embed Post

Puppy created a new Press Release.
MindMed’s (MNMD) Nasdaq debut Tuesday made it the second psychedelic drug developer to be listed on a major U.S. stock exchange. UK-based Compass Pathways (CMPS) went public on the Nasdaq in September, while last week ATAI Life Sci. filed for a IPO
10 0
17489 views
Comment
Comments (0)
  •    No comments.